Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland

Multiple Sclerosis (MS) is the most common, primary neurogenic cause of disability among young adults. We investigated demographic and clinical factors associated with unemployment on the example of 150 MS patients receiving immunomodulatory treatment in Poland. This study was based on clinical eval...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2018-04, Vol.13 (4), p.e0194117
Main Authors: Koziarska, Dorota, Król, Joanna, Nocoń, Danuta, Kubaszewski, Przemysław, Rzepa, Teresa, Nowacki, Przemysław
Format: Article
Language:English
Subjects:
Adolescent
Adult
Adults
Analysis
Biology and Life Sciences
Care and treatment
Caregivers
Demographic aspects
Demographics
Disability Evaluation
Disabled Persons
Disease Progression
Employment
Families & family life
Fatigue
Female
Health aspects
Humanities
Humans
Immunologic Factors - therapeutic use
Immunomodulation
Immunotherapy
Male
Medical diagnosis
Medicine and Health Sciences
Middle Aged
Motivation
Multiple sclerosis
Multiple Sclerosis - drug therapy
Multiple Sclerosis - epidemiology
Neurology
Patients
People and Places
Poland
Poland - epidemiology
Prevalence studies (Epidemiology)
Risk Factors
Social Sciences
Studies
Surveys and Questionnaires
Unemployment
Young Adult
Young adults
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Multiple Sclerosis (MS) is the most common, primary neurogenic cause of disability among young adults. We investigated demographic and clinical factors associated with unemployment on the example of 150 MS patients receiving immunomodulatory treatment in Poland. This study was based on clinical evaluation and collection of self-reported questionnaires, with an attention to self-motivation, severe fatigue and moderate disability. Patients who were unemployed (40% of all patients) had a mean disease duration of almost 5 years. Older (p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0194117